
Timothy P. Thomas
Examiner (ID: 14485, Phone: (571)272-8994 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1628, 1611, 1609, 1614 |
| Total Applications | 1262 |
| Issued Applications | 269 |
| Pending Applications | 136 |
| Abandoned Applications | 889 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16153693
[patent_doc_number] => 20200215079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => Ophthalmic Pharmaceutical Composition, Ophthalmic Kit, and Pharmaceutical Application Thereof
[patent_app_type] => utility
[patent_app_number] => 16/649268
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/649268 | Ophthalmic pharmaceutical composition, ophthalmic kit, and pharmaceutical application thereof | Sep 19, 2018 | Issued |
Array
(
[id] => 14185437
[patent_doc_number] => 20190112423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => REVERSIBLY CROSSLINKED MICELLE SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/131644
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16131644
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/131644 | Reversibly crosslinked micelle systems | Sep 13, 2018 | Issued |
Array
(
[id] => 14226975
[patent_doc_number] => 20190125660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => Orally dissolving mucoadhesive films utilizing menthol and l-arginine to enhance the bioavailability of cannabinoids
[patent_app_type] => utility
[patent_app_number] => 16/350011
[patent_app_country] => US
[patent_app_date] => 2018-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16350011
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/350011 | Orally dissolving mucoadhesive films utilizing menthol and l-arginine to enhance the bioavailability of cannabinoids | Sep 11, 2018 | Abandoned |
Array
(
[id] => 16282607
[patent_doc_number] => 20200276209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => METHODS OF TREATING EPILEPSY OR STATUS EPILEPTICUS
[patent_app_type] => utility
[patent_app_number] => 16/645975
[patent_app_country] => US
[patent_app_date] => 2018-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/645975 | METHODS OF TREATING EPILEPSY OR STATUS EPILEPTICUS | Sep 10, 2018 | Abandoned |
Array
(
[id] => 16153547
[patent_doc_number] => 20200215006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => TOPICAL COMPOSITIONS AND METHODS FOR TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/646120
[patent_app_country] => US
[patent_app_date] => 2018-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37084
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646120
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646120 | TOPICAL COMPOSITIONS AND METHODS FOR TREATMENT | Sep 9, 2018 | Abandoned |
Array
(
[id] => 15193805
[patent_doc_number] => 10494381
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Compounds that inhibit Mcl-1 protein
[patent_app_type] => utility
[patent_app_number] => 16/123030
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 42810
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/123030 | Compounds that inhibit Mcl-1 protein | Sep 5, 2018 | Issued |
Array
(
[id] => 16482297
[patent_doc_number] => 20200375897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => COMPOSITION FOR CALCIUM SUPPLEMENTATION
[patent_app_type] => utility
[patent_app_number] => 16/644279
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644279
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/644279 | COMPOSITION FOR CALCIUM SUPPLEMENTATION | Sep 5, 2018 | Abandoned |
Array
(
[id] => 13774877
[patent_doc_number] => 20190000977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => CORTICOSTEROID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/123924
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123924
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/123924 | CORTICOSTEROID COMPOSITIONS | Sep 5, 2018 | Abandoned |
Array
(
[id] => 13840471
[patent_doc_number] => 20190023720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
[patent_app_type] => utility
[patent_app_number] => 16/121750
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16121750
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/121750 | Compounds that inhibit MCL-1 protein | Sep 4, 2018 | Issued |
Array
(
[id] => 16710279
[patent_doc_number] => 20210077426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => ANALGESIC FORMULATION FOR CONTROL OF PAIN IN DOGS
[patent_app_type] => utility
[patent_app_number] => 16/644776
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644776
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/644776 | Analgesic formulation for control of pain in dogs | Sep 4, 2018 | Issued |
Array
(
[id] => 16175409
[patent_doc_number] => 20200222377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => Methods Of Enhancing And/Or Stabilizing Cardiac Function In Patients With Fabry Disease
[patent_app_type] => utility
[patent_app_number] => 16/642620
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642620
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642620 | Methods Of Enhancing And/Or Stabilizing Cardiac Function In Patients With Fabry Disease | Aug 27, 2018 | Pending |
Array
(
[id] => 17297837
[patent_doc_number] => 20210393676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => APPLICATION OF HONOKIOL IN ANTI-OTOTOXICITY AND HEARING PROTECTION
[patent_app_type] => utility
[patent_app_number] => 16/639669
[patent_app_country] => US
[patent_app_date] => 2018-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16639669
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/639669 | APPLICATION OF HONOKIOL IN ANTI-OTOTOXICITY AND HEARING PROTECTION | Aug 16, 2018 | Abandoned |
Array
(
[id] => 16466653
[patent_doc_number] => 20200368190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => METHODS OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/636608
[patent_app_country] => US
[patent_app_date] => 2018-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16636608
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/636608 | METHODS OF TREATMENT | Aug 6, 2018 | Abandoned |
Array
(
[id] => 13898625
[patent_doc_number] => 20190038517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => BAMBOO FIBERS IN A HIGH-DEFINITION NATURAL-BASED MASCARA FOR EYELASHES AND EYEBROWS
[patent_app_type] => utility
[patent_app_number] => 16/047461
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16047461
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/047461 | BAMBOO FIBERS IN A HIGH-DEFINITION NATURAL-BASED MASCARA FOR EYELASHES AND EYEBROWS | Jul 26, 2018 | Abandoned |
Array
(
[id] => 16108401
[patent_doc_number] => 20200206223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => LIQUID DOSAGE FORMS OF IMATINIB
[patent_app_type] => utility
[patent_app_number] => 16/633048
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633048
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633048 | LIQUID DOSAGE FORMS OF IMATINIB | Jul 25, 2018 | Abandoned |
Array
(
[id] => 14759593
[patent_doc_number] => 10391177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Methods for treating cancer using 6,8-bis (benzylthio) octanonic acid
[patent_app_type] => utility
[patent_app_number] => 16/039799
[patent_app_country] => US
[patent_app_date] => 2018-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 16584
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16039799
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/039799 | Methods for treating cancer using 6,8-bis (benzylthio) octanonic acid | Jul 18, 2018 | Issued |
Array
(
[id] => 13518039
[patent_doc_number] => 20180310562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => FUNGICIDAL PYRAZOLE MIXTURES
[patent_app_type] => utility
[patent_app_number] => 16/029818
[patent_app_country] => US
[patent_app_date] => 2018-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16029818
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/029818 | FUNGICIDAL PYRAZOLE MIXTURES | Jul 8, 2018 | Abandoned |
Array
(
[id] => 16434838
[patent_doc_number] => 20200352163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => ANTIMICROBIAL MIXTURE CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE AND AN AROMATIC ALCOHOL, AND COSMETIC COMPOSITION CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 16/626100
[patent_app_country] => US
[patent_app_date] => 2018-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16626100
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/626100 | ANTIMICROBIAL MIXTURE CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE AND AN AROMATIC ALCOHOL, AND COSMETIC COMPOSITION CONTAINING SAME | Jun 26, 2018 | Pending |
Array
(
[id] => 16153683
[patent_doc_number] => 20200215074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => Method of Treatment of Cancer
[patent_app_type] => utility
[patent_app_number] => 16/624439
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16624439
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/624439 | Method of Treatment of Cancer | Jun 21, 2018 | Abandoned |
Array
(
[id] => 16175361
[patent_doc_number] => 20200222329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => ABUSE DETERRENT ORAL SOLID DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 16/625271
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9070
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625271
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625271 | Abuse deterrent oral solid dosage form | Jun 21, 2018 | Issued |